Fatal pulmonary toxicity in a patient treated with gefitinib for non-small cell lung cancer after previous hemolytic-uremic syndrome due to gemcitabine.

Rabinowits, Guilherme

Fatal pulmonary toxicity in a patient treated with gefitinib for non-small cell lung cancer after previous hemolytic-uremic syndrome due to gemcitabine. [electronic resource] - Anti-cancer drugs Sep 2003 - 665-8 p. digital

Publication Type: Case Reports; Journal Article

0959-4973

10.1097/00001813-200309000-00014 doi


Aged
Antineoplastic Agents--adverse effects
Carcinoma, Non-Small-Cell Lung--drug therapy
Deoxycytidine--adverse effects
Female
Gefitinib
Hemolytic-Uremic Syndrome--chemically induced
Humans
Lung--diagnostic imaging
Lung Neoplasms--drug therapy
Quinazolines--adverse effects
Tomography, X-Ray Computed
Gemcitabine